Claudin-18 coupled with EGFR/ERK signaling contributes to the malignant potentials of bile duct cancer

This publication has 20 references indexed in Scilit:

• Nuclear localization of tricellulin promotes the oncogenic property of pancreatic cancer
  Scientific Reports, 2016
• Claudins in cancer: bench to bedside
  Pflügers Archiv - European Journal of Physiology, 2016
• An immunohistochemical marker panel including claudin-18, maspin, and p53 improves diagnostic accuracy of bile duct neoplasms in surgical and presurgical biopsy specimens
  Virchows Archiv, 2014
• Claudins and the Modulation of Tight Junction Permeability
  Physiological Reviews, 2013
• Tight junction‐related human diseases
  Pathology International, 2013
• Claudin-18 in biliary neoplasms. Its significance in the classification of intrahepatic cholangiocarcinoma
  Virchows Archiv, 2011
• Transcriptional regulation of claudin‐18 via specific protein kinase C signaling pathways and modification of DNA methylation in human pancreatic cancer cells
  Journal of Cellular Biochemistry, 2011
• Vandetanib (ZD6474), an inhibitor of VEGFR and EGFR signalling, as a novel molecular-targeted therapy against cholangiocarcinoma
  British Journal of Cancer, 2009
• Transcriptional activation of the humanclaudin-18gene promoter through two AP-1 motifs in PMA-stimulated MKN45 gastric cancer cells
  American Journal of Physiology-Gastrointestinal and Liver Physiology, 2008
• Biliary tract cancer treatment: results from the Biliary Tract Cancer Statistics Registry in Japan
  Journal of Hepato-Biliary-Pancreatic Surgery, 2002